Tag: FDA 505A
Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs Without Changing Patents
Pediatric exclusivity gives drugmakers six extra months of market protection by blocking generic approvals-even after patents expire. It's not a patent extension, but a powerful FDA tool that ensures safer pediatric drug data.
Categories: Medications
4